Sigma-Aldrich Corp has acquired all outstanding shares of Cerilliant Corp, Round Rock, Tex, to strengthen its analytical chemistry product portfolio and to continue to deliver on its strategic growth plans.
Read MoreThe company has closed on $6.0 million of financing from Third Security LLC to fund the cash portion of Transgenomic’s acquisition of Clinical Data’s diagnostic business.
Read More
Pathology labs face challenges and opportunities similar to core areas.
Read More
The challenges of HITECH, streamlining workflow and results processes and partnerships and acquisitions.
Read More
New assays make testing more efficient for labs, more effective for patients.
Read More